Keyphrases
Acute Coronary Syndrome
20%
Acute Myeloblastic Leukemia
19%
Aneuploidy
19%
Apoptosis
24%
B-cell Lymphoma 2 (Bcl-2)
19%
B-CLL
22%
Bone Marrow
30%
Breast Cancer
21%
Breast Cancer Cells
31%
Cancer in Pregnancy
36%
Chemotherapy
66%
Chronic Lymphocytic Leukemia
69%
Chronic Myeloid Leukemia
40%
Confidence Interval
24%
Doxorubicin
30%
During Pregnancy
85%
Enalapril
24%
Essential Thrombocythemia
21%
Eukaryotic Translation Initiation Factor 4E (eIF4E)
28%
Fetal Outcome
19%
Fetus
39%
First Trimester
51%
Fluorescence in Situ Hybridization
65%
Hazard Ratio
18%
Heat Shock Protein 27 (HSP27)
23%
Hematological Malignancies
22%
Hodgkin Lymphoma
18%
Human Mesenchymal Stem Cells (hMSCs)
28%
Human Placenta
17%
Leukemia
27%
Leukemia Patients
35%
Lymphoma
49%
Lymphoma Patients
34%
Malignancy
34%
Mesenchymal Stem Cells
22%
Microvesicles
22%
Multiple Myeloma
100%
Myeloma Cells
72%
Non-Hodgkin Lymphoma
48%
Non-pregnant Women
35%
Placenta
39%
Polycythemia Vera
22%
Pregnancy-associated Cancer
17%
Pregnant Women
55%
Risk Factors
20%
Simvastatin
36%
Statins
24%
Termination of Pregnancy
18%
Tetraspanin
31%
Translation Initiation
26%
Medicine and Dentistry
Acute Leukemia
11%
Antiphospholipid Syndrome
11%
B-Cell Chronic Lymphocytic Leukemia
29%
Biopsy
14%
Bone Marrow Mesenchymal Stem Cell
18%
Breast Cancer
52%
Cancer
45%
Cancer Cell
40%
Cardiovascular Disease
16%
Cell Death
13%
Cell Migration
12%
Cervical Cancer
11%
Chronic Myelogenous Leukemia
18%
Congenital Malformation
23%
Diabetes Mellitus
13%
Diagnosis
21%
Disease
39%
Doxorubicin
23%
Drug Therapy
14%
Extracellular Matrix
14%
First Trimester Pregnancy
47%
Flow Cytometry
12%
Fluorescence in Situ Hybridization
17%
Hematologic Malignancy
16%
Hodgkin's Lymphoma
26%
In Vitro
18%
Initiation Factor
14%
Initiation Factor 4E
16%
Ischemic Heart Disease
18%
Leukemia
17%
Leukocyte
12%
Malignant Neoplasm
84%
Maturity Onset Diabetes of the Young
15%
MCF-7
11%
Mesenchymal Stem Cell
13%
Metastatic Carcinoma
18%
Multiple Myeloma
80%
Multiple Myeloma Cell Line
15%
Myeloma Cell
44%
Myeloma Cell Line
19%
Neoplasm
16%
Nodular Melanoma
14%
Non-Hodgkin Lymphoma
38%
Patient with Non-Hodgkins Lymphoma
14%
Placenta
35%
Pregnancy Termination
18%
Simvastatin
13%
Symptom
16%
Tetraspanin
21%
Translation Initiation
22%